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Abstract
Background: This study was designed to quantify the resources used in reestablishing contact
with women who missed their scheduled cervical cancer screening visits and to assess the success
of this effort in reducing loss to follow-up in a developing country setting.
Methods: Women were enrolled in this Cape Town, South Africa-based screening study between
2000 and 2003, and all had scheduled follow-up visits in 2003. Community health worker (CHW)
time, vehicle use, maintenance, and depreciation were estimated from weekly logs and cost
accounting systems. The percentage of women who attended their scheduled visit, those who
attended after CHW contact(s), and those who never returned despite attempted contact(s) were
determined. The number of CHW visits per woman was also estimated.
Results: 3,711 visits were scheduled in 2003. Of these, 2,321 (62.5%) occurred without CHW
contact, 918 (24.8%) occurred after contact(s), and 472 (12.7%) did not occur despite contact(s).
Loss to follow-up was reduced from 21% to 6%, 39% to 10%, and 50% to 24% for 6, 12, and 24-
month visits. CHWs attempted 3,200 contacts in 530 trips. On average, 3 CHWs attempted to
contact 6 participants over each 111 minute trip. The per-person cost (2003 Rand) for these
activities was 12.75, 24.92, and 40.50 for 6, 12, and 24-month visits.
Conclusion: CHW contact with women who missed scheduled visits increased their return rate.
Cost-effectiveness analyses aimed at policy decisions about cervical cancer screening in developing
countries should incorporate these findings.
Background
The vast majority of cervical cancer deaths occur among
women in developing countries where screening has been
largely unavailable [1]. The effectiveness of cervical cancer
screening has been demonstrated by the dramatic decline
of cervical cancer in developed countries in which pro-
grams relying on repeated cervical Pap smears have been
successfully implemented [2,3].
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Traditionally, conventional cervical cancer screening
using cervical cytology requires up to three visits (screen-
ing, colposcopy/biopsy, and treatment). In developed
country settings, HPV DNA testing has been proposed
both as a primary screening test in older women and in
conjunction with cervical cytology as triage for equivocal
cytologic results [4,5]. Recently, others have proposed
using either cervical cytology or HPV DNA testing in two-
visit strategies that eliminate confirmation with colpos-
copy/biopsy prior to treatment, or using one-visit, "see
and treat" strategies with visual inspection with acetic acid
(VIA) [6-8]. Regardless of the screening test chosen, an
important motivation for these alternative strategies is to
reduce the screening program's susceptibility to loss to
follow-up by reducing the number of visits at which loss
to follow-up can occur [9-11].
A number of cost-effectiveness analyses (CEAs) have been
conducted, comparing many of these screening strategies
in developing country contexts [12-14]. One key finding
is that for screening strategies that require women to
return to the clinic multiple times, loss to follow-up drives
down the effectiveness of screening, regardless of screen-
ing modality. Furthermore, the cost of screening accrues
as each woman is screened. The primary benefit from
screening, the prevention of cervical cancer, is only real-
ized for those women with positive test results and true
precancerous lesions who are ultimately treated.
In low resource settings, levels of loss to follow-up in cer-
vical cancer screening programs where follow-up visits
were scheduled four weeks or more after the initial visit
range from 10% to 70% [10,15-21]. Efforts to reduce loss
to follow-up and to maintain it at an acceptably low level
are thus a key part of cervical cancer screening programs.
Such efforts can be time-intensive and costly and do not
guarantee that all women return to the clinic for follow-
up. Quantifying the cost and effectiveness associated with
achieving acceptably low levels of loss to follow-up is
essential for providing an estimate of the investment nec-
essary to achieve cervical cancer screening coverage at the
population level as well as for estimating the true cost-
effectiveness of cervical cancer screening in these settings.
We used year 2003 data from the Khayelitsha Cervical
Cancer Screening Program (KCCSP), a multi-year, South
African program, to examine the success of CHW home
visits in reducing loss to follow-up as well as the extent
and type of resources used in this effort.
Methods
Study setting
The Khayelitsha Cervical Cancer Screening Program
encompasses a multi-year, multi-site study designed to
evaluate the effectiveness of a variety of cervical cancer
screening and treatment strategies among a largely poor,
black, peri-urban, South African population in a real-
world setting. Approximately 25% of participants live in
informal settlements without basic services such as elec-
tricity and water, and another 45% live in informal settle-
ments with some basic services. The remaining 30% live
in formal settlements.
At each scheduled appointment, women are tested with
cervical cytology, HPV DNA testing using Hybrid Capture
II, and visual inspection with acetic acid. The program has
generated data that support the effectiveness and cost-
effectiveness of various screening strategies [11,22,23]. In
an effort to minimize loss to follow-up, CHWs drive
throughout the community to visit women in their homes
if they have missed appointments. Home visits by CHWs
are used because most participants do not have tele-
phones.
Study population
All study participants who had appointments in 2003
were considered eligible for inclusion in the main analy-
sis. Study participants had one or more of four different
types of appointments scheduled for during this period: 6-
month, 12-month, 24-month, and 36-month visits. We
restricted our analysis of CHW home visit effectiveness
and examined the first three types of appointments
because the number of 36-month appointments in 2003
was small (n = 277) relative to 6-month (n = 919), 12-
month (n = 1820), and 24-month (n = 980) appoint-
ments.
KCCSP was approved by the Institutional Review Boards
of Columbia University and the University of Cape Town,
and all study participants gave written informed consent.
CHW Visits for Participants with Appointments in the First  Half of 2003 Figure 1
CHW Visits for Participants with Appointments in 
the First Half of 2003. The distribution of the number of 
CHW home visits for those women who eventually returned 
for their appointments (black bars) and those women who 
never returned for their appointments (white bars).Cost Effectiveness and Resource Allocation 2005, 3:11 http://www.resource-allocation.com/content/3/1/11
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Effectiveness
To assess the effectiveness of CHW home visits, we esti-
mated the number of appointments that would have been
missed due to loss to follow-up and the percentage of
these appointments rescheduled and attended due to
home visits. We accounted for the possibility that each
participant might have more than one appointment
within the period of this study and that CHWs might
make more than one home visit per participant.
Participant study number, entries for all scheduled
appointments during 2003, and the date(s) on which the
participant arrived for these appointments were extracted
from the main study database. This data was linked to
data transcribed from weekly forms used by CHWs to
record participant study numbers and the date of the
CHW visits. Using the date of the scheduled appointment,
the date of the CHW visit(s), and the date on which the
participant actually visited the clinic, the appointment
type for which the participant was visited was identified.
Using this method, those participants who had been vis-
ited by CHW but never returned for their appointments
were also identified. Similar estimates subcategorized by
appointment type were also generated.
Costs
To estimate costs, we first identified the different types of
resources used in the CHW home visits. Resources
included the time the CHWs spent driving to and from as
well as visiting participants who had missed appoint-
ments, fuel used during the trips to visit participants, and
the maintenance and depreciation in the value of the vehi-
cles. Next, the average monetary value for each resource
type was estimated. Finally, the estimated quantity of each
type of resource was multiplied by its estimated monetary
value, and the results were then summed to calculate the
total cost of the effort to reduce loss to follow-up.
The quantity of CHW time used for visits was derived
from weekly reporting sheets that identified the amount
of time spent making home visits each day, the study
number of each participant visited, and the CHWs who
went on each visit. The value of CHW time was estimated
in two ways. First, the salary scale employed within the
study was used to estimate the actual cost to the study.
Second, South African health worker wage scales were
used to estimate the cost of CHW time if such an effort
were conducted within the national health system.
The costs of fuel and maintenance for vehicles used by the
CHWs to make their visits were extracted from the study's
cost accounting system. The system produced monthly
reports detailing fuel and maintenance costs for each
study vehicle. Since the vehicles were also used for other
tasks such as transportation of specimens to laboratories
for analysis, only a percentage of the total vehicle costs
were truly attributable to the CHW visits. This percentage
was calculated as the relative proportion of time that each
vehicle was used by the CHWs to make home visits.
Vehicle depreciation was estimated based on the initial
purchase price of the vehicles, the expected useful life of
each vehicle, and the assumption that the final resale
value of the vehicle would be negligible. Straight line
depreciation was employed to calculate the total depreci-
ation for one year, using a 3% discount rate [24,25]. The
same percentage of fuel and maintenance costs attributa-
ble to CHW visits was applied to the total vehicle depreci-
ation cost to calculate vehicle depreciation attributable to
CHW visits.
All costs are presented in 2003 South African Rand and do
not include any form of tax since taxes represent transfer
payments and are not real economic costs [24]. The
exchange rate between 2003 South African Rand and 2003
US Dollars was 7.56 Rand per Dollar [26].
CHW visits
Since it was possible that multiple participants were vis-
ited on each CHW trip; that more than one CHW went on
each trip; and that some participants received multiple
CHW visits, we accounted for this in our estimates using
data from the weekly CHW visit logs. To minimize poten-
tial bias of the number of CHW visits per participant due
to censoring (e.g., additional CHW visits in early 2004 not
counted for participants first visited in December of
2003), data on average number of CHW visits per partici-
pant was based solely on participants with scheduled
appointments in the first half of 2003.
Cost per appointment
Based upon the total number of CHW home visits con-
ducted and the total cost to carrying out these home visits,
a cost per CHW home visit was calculated. Cost per
woman screened was calculated by appointment type
because the time since the previous visit differed by
appointment type: 1) 5 months between the 1-month
visit and the 6-month visit; 2) 6 months between the 6-
Table 1: Community Health Worker Visits to Participants
Estimate SD
CHWs per trip (trips = 457)* 2.82 0.85
Participants visited per trip (trips = 530)* 5.65 2.46
Time per trip (min) (trips = 386)* 111.32 52.60
Time per participant visited (min) (trips = 386)* 22.09 12.87
* The numbers of trips for these parameters differ because not all 
information was provided on all weekly report forms. To calculate 
ratios, only trips for which all information was available were included.Cost Effectiveness and Resource Allocation 2005, 3:11 http://www.resource-allocation.com/content/3/1/11
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month visit and the 12-month visit; 3) 12 months
between the 12-month visit and the 24-month visit. To do
this, the ratio of the number of CHW visits conducted for
a particular appointment type to the total number of
women attending that appointment type was calculated.
Then, this ratio was multiplied by the cost per CHW visit
to derive the marginal cost per woman for CHW home vis-
its.
Ranges and sensitivity analyses
Because there was uncertainty in a number of parameters
used to estimate total cost, we estimated an upper and
lower bound for costs, reflecting a combination of differ-
ing assumptions regarding salary and percentage of vehi-
cle costs attributable to CHW home visits. Because it was
necessary to infer the appointment type for which CHW
home visits were attempting to reduce loss to follow-up,
we applied alternate assumptions to generate ranges of
estimates of cost per woman screened.
Results
Effectiveness of CHW visits
Potential loss to follow-up differs by appointment type as
does the success of CHW visits in preventing loss to fol-
low-up. Figure 1 shows the distribution of the number of
visits for participants with appointments in the first half of
2003 who returned for their appointments after CHW vis-
its and for those who did not return. For those women
who missed their scheduled appointment, the mean
number of CHW visits was 1.98 for those with 6-month
appointments, 2.06 for those with 12-month appoint-
ments, and 2.05 for those with 24-month appointments.
Figure 2 shows the percentage of women who returned
without CHW visits, the percentage of women who
returned after CHW visits, and those who did not return
despite CHW visits. Without CHW visits, loss to follow-up
for participants scheduled for 6 month, 12 month, and
24-month visits would have been 21%, 39%, and 50%
Appointments Attended by Type and CHW Visit Status Figure 2
Appointments Attended by Type and CHW Visit Status. The number and percentage of women who attended 
appointments without CHW home visits (green bars), women who attended appointments after CHW home visits (yellow 
bars), and women who never returned for their appointments (red bars) for each appointment type.Cost Effectiveness and Resource Allocation 2005, 3:11 http://www.resource-allocation.com/content/3/1/11
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respectively. With CHW visits, loss to follow-up was
reduced to 6%, 10%, and 24% respectively.
Quantities of resources used
CHW home visits involve groups of CHWs driving into
Khayelitsha and surrounding township areas to visit study
participants who have not returned to the clinic for their
scheduled appointments. For security reasons, CHWs
travel in groups of up to four, with larger groups generally
going when informal settlements are visited.
In total, CHWs conducted approximately 3,200 visits in
530 trips during 2003. Means for staff per trip, partici-
pants visited per trip, time per trip, and time per partici-
pant visit were calculated along with their standard
deviations from weekly CHW home visit logs (Table 1).
Primary observations of CHWs were conducted on several
days to corroborate the information contained in the
weekly logs. This observation found average visit time was
20.75 minutes (SD = 8.56, participants = 16). This
matched the information from the reports (22.09 min-
utes, SD = 12.87, trips = 386). Additionally, it was found
that approximately 70% of the participant visit time was
spent driving between each participant's home.
On the 230 days per year that the project operates, its vehi-
cles are used for three main purposes, staff transport, spec-
imen transport, and CHW visits to participants.
Approximately three hours per day are spent on staff and
specimen transport. Approximately four hours and 20
minutes are spent on CHW visits per day with 70% of this
time spent driving. Thus, 50% of the vehicles' costs are
allocated to CHW visits.
Costs of resources used
Average monthly salaries for CHWs working for the
KCCSP are approximately 4000 Rand, while average sala-
ries for CHWs working in South Africa are approximately
2000 Rand per month.
The project operates four vehicles. The purchase price of
each vehicle was approximately 40,000 Rand, excluding
taxes. The mean and standard deviation of yearly fuel
costs per vehicle are 9,111 Rand (SD = 1,735). The mean
and standard deviation of yearly maintenance costs are
6,761 Rand (SD = 2,189). Using a 3% discount rate and
five year, straight line depreciation, the yearly deprecia-
tion cost of each vehicle was 8,684 Rand. Table 2 presents
the component costs attributable to CHW visits.
Cost per screened participant
The cost per CHW visit was 28.32 Rand. If the higher study
CHW wage of 4,000 Rand per month was used and 80%
of CHW visit time was spent driving, the estimate
increases to 39.96 Rand per CHW visit. If an even lower,
public sector wage of 1,500 Rand per month and 50% of
CHW visit time was spent driving, the estimate decreases
to 21.14 Rand per CHW visit.
To attribute these costs on a per-screened participant
basis, it is necessary to examine the relative number of
appointments and relative effectiveness of CHW visits at
reducing loss to follow-up for 6, 12, and 24-month
appointments. Table 3 shows the results of this analysis.
Because of high success in CHW visits leading to partici-
pant return, 6-month per participant costs are 12.75 Rand.
There is an increasing trend in per participant costs for the
12 and 24-month visits, with per participant cost equaling
24.92 Rand and 40.50 Rand respectively.
There was some ambiguity in the participant data as to
which appointment type a particular CHW visit should be
attributed. For example, for a participant with 6 and 12-
month appointments within 2003 who missed both
appointments and who received 4 CHW visits, it was not
always clear which CHW visits led to attendance at each
appointment. In the base case, we attributed the total
number of CHW visits to both appointments since sepa-
rate cost per woman estimates were calculated. However,
this provides an overestimate of costs.
Two other alternatives were explored. In the first alterna-
tive, the earlier appointment was assumed to be the
appointment for which all CHW home visits were neces-
sary. In the second alternative, when such an ambiguity
existed, the count of CHW visits was divided evenly
between the two appointments.
Figure 3 shows the CHW home visit cost per woman using
different inference rules to assign CHW home visits to the
various appointment types. Per-woman screened costs
ranged from 8.59–12.62 Rand, 20.65–24.89 Rand, and
39.42–40.45 Rand for 6, 12, and 24-month appointments
respectively.
Table 2: Component Costs Attributable to CHW Visits (2003 
Rand)
Estimate
CHW Time Cost 43,335
Fuel Cost 18,222
Maintenance Cost 13,522
Depreciation Cost 17,368
Total Cost 92,447Cost Effectiveness and Resource Allocation 2005, 3:11 http://www.resource-allocation.com/content/3/1/11
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Discussion
The objective of this study was to estimate the costs and
effectiveness associated with an intervention to reduce the
loss to follow-up after an initial cervical cancer screening
visit in a South African screening program delivered to
women of lower socio-economic status. We found that
loss to follow-up was reduced significantly by community
health worker home visits, and this effect was most pro-
nounced when the intervention occurred in close proxim-
ity to the initial appointment. The costs of the CHW
intervention were substantial when considered in the con-
text of the total per-woman cost of cervical cancer screen-
ing. The CHW home visit costs were 8–15%, 15–29%, and
25–47% of the total per-woman screened cost for 6, 12,
and 24-month visits [13].
Ultimately, the costs of cervical cancer screening including
efforts to reduce loss to follow-up must be considered in
relationship to the level of cervical cancer reduction. In an
ethical study conducted in a reasonable time-frame, it
would not be possible to measure actual reduction in cer-
vical cancer incidence due to reduction in loss to follow-
up. Thus, model-based studies are best suited to use our
estimates to refine results from previous cost-effectiveness
analyses of cervical cancer screening programs in develop-
ing countries. In addition, analysts conducting cost stud-
ies for short-term budgetary planning might wish to
include these costs to reflect the full range of resources
likely to be required in a new cervical cancer screening
program.
This study has several limitations. First, we relied on data
from a single year derived from sites in one peri-urban
township outside of Cape Town. While the areas where
participants live are spread over kilometers of land and in
the winter rainy seasons, the unpaved roads of the infor-
mal settlements become difficult to navigate, the general-
izability of these results to other parts of South Africa or,
for that matter, to other developing countries is uncertain.
Second, the data were derived from CHW home visits con-
nected to a clinical research study. Possible selection
biases may operate to make participants more or less
likely to miss clinical appointments or to respond to
efforts to reduce loss to follow up. Because the staff is bet-
ter paid and likely better trained than average public sec-
tor CHWs, differences in competence and motivation
level may also impact the success if this effort were to be
replicated elsewhere. Third, other methods of reducing
loss to follow-up such as telephone calls, letters, and spe-
cifically-targeted preventive educational sessions were not
evaluated as alternatives to CHW visits. Because most par-
ticipants reported not having telephones and because of
difficulties in timely and accurate mail deliveries to all
participants, we believe that these interventions were less
appropriate for reducing loss to follow-up in this setting.
An important question remains as to whether other
potentially less costly and/or more effective methods exist
to reduce loss to follow-up. Finally, the sustainability of
this effort over many years and locations has not been
tested.
To reflect the variability and uncertainty inherent in deliv-
ering cervical cancer screening services we have produced
plausible ranges of costs and effectiveness for efforts to
reduce loss to follow-up. Such estimates of the costs and
effectiveness of reducing loss to follow-up should be con-
sidered as programs are planned and scaled-up to
national population coverage levels.
Conclusion
In a South African cervical cancer screening study, loss to
follow-up was reduced by CHW visits to women who had
not attended their regularly scheduled appointments. The
effectiveness of the CHW intervention was higher for
appointments scheduled closer to initial screening visits.
The total costs associated with CHW visits were apprecia-
ble, and the per-woman cost increased as the time
between initial appointment and scheduled appointment
increased. The cost-effectiveness of preventing loss to fol-
Table 3: CHW Visit Cost Attribution by Appointment Type (2003 Rand)
6-Month Visit 12-Month Visit 24-Month Visit
Participants Attending 
Appointments
861 1,635 743
CHW Visits Conducted 384 1,438 1,062
Visits per Participant 0.45 0.88 1.43
CHW Visit Cost per Participant 
(base case)
12.75 24.92 40.50
CHW Visit Cost per Participant 
(lower estimate)
9.51 18.60 30.23
CHW Visit Cost per Participant 
(upper estimate)
17.98 35.16 57.14Cost Effectiveness and Resource Allocation 2005, 3:11 http://www.resource-allocation.com/content/3/1/11
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low-up is an important consideration in planning
national screening programs in resource poor settings
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